Lifecore Biomedical, Inc. (LFCR)
NASDAQ: LFCR · IEX Real-Time Price · USD
4.850
-0.240 (-4.72%)
At close: Jul 19, 2024, 4:00 PM
4.860
+0.010 (0.21%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

Lifecore Biomedical Revenue

In the fiscal year ending May 28, 2023, Lifecore Biomedical had annual revenue of $103.27M. Revenue in the quarter ending May 28, 2023 was $25.52M with 20.78% year-over-year growth.

Revenue (ttm)
$103.27M
Revenue Growth
-7.19%
P/S Ratio
1.45
Revenue / Employee
$224,987
Employees
459
Market Cap
149.69M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
May 28, 2023103.27M-8.00M-7.19%
May 29, 2022111.27M10.40M10.31%
May 30, 2021100.87M-59.19M-36.98%
May 31, 2020160.07M-397.49M-71.29%
May 26, 2019557.56M33.33M6.36%
May 27, 2018524.23M54.45M11.59%
May 28, 2017469.78M-7.14M-1.50%
May 29, 2016476.92M-62.34M-11.56%
May 31, 2015539.26M62.44M13.10%
May 25, 2014476.81M35.11M7.95%
May 26, 2013441.71M124.16M39.10%
May 27, 2012317.55M40.82M14.75%
May 29, 2011276.73M38.51M16.16%
May 30, 2010238.22M2.29M0.97%
May 31, 2009235.94M-2.59M-1.09%
May 25, 2008238.53M28.03M13.32%
May 27, 2007210.50M-21.46M-9.25%
May 28, 2006231.95M26.72M13.02%
May 29, 2005205.23M13.14M6.84%
May 30, 2004192.09M8.94M4.88%
Oct 27, 2002183.16M-7.49M-3.93%
Oct 28, 2001190.65M-6.58M-3.34%
Oct 29, 2000197.23M175.78M819.64%
Oct 31, 199921.45M-12.07M-36.01%
Oct 31, 199833.52M24.00M252.21%
Oct 31, 19979.52M7.45M360.38%
Oct 31, 19962.07M-1.39M-40.26%
Oct 31, 19953.46M1.76M103.53%
Oct 31, 19941.70M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
High Tide 503.78M
Quipt Home Medical 185.39M
Capricor Therapeutics 27.10M
Zomedica 25.97M
ProQR Therapeutics 14.66M
Vaxart 8.89M
Revenue Rankings